Loading…

Correlation Between Serum and Tissue SIRT1 Levels in Patients With Esophageal Squamous Cell Carcinoma

Identifying prognostic and molecular markers as therapeutic targets for esophageal squamous cell carcinoma (ESCC) could enhance the efficacy of multidisciplinary treatments. While tissue expression of sirtuin 1 (SIRT1) has been linked to tumor progression in ESCC, prognostic significance of serum SI...

Full description

Saved in:
Bibliographic Details
Published in:Cancer diagnosis & prognosis 2024-11, Vol.4 (6), p.762-768
Main Authors: Morishita, Hiroki, Otsuka, Ryota, Toyozumi, Takeshi, Matsumoto, Yasunori, Sekino, Nobufumi, Okada, Koichiro, Shiraishi, Tadashi, Kamata, Toshiki, Iida, Shinichiro, Makiyama, Tenshi, Nishioka, Yuri, Yamada, Masanari, Matsubara, Hisahiro
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 768
container_issue 6
container_start_page 762
container_title Cancer diagnosis & prognosis
container_volume 4
creator Morishita, Hiroki
Otsuka, Ryota
Toyozumi, Takeshi
Matsumoto, Yasunori
Sekino, Nobufumi
Okada, Koichiro
Shiraishi, Tadashi
Kamata, Toshiki
Iida, Shinichiro
Makiyama, Tenshi
Nishioka, Yuri
Yamada, Masanari
Matsubara, Hisahiro
description Identifying prognostic and molecular markers as therapeutic targets for esophageal squamous cell carcinoma (ESCC) could enhance the efficacy of multidisciplinary treatments. While tissue expression of sirtuin 1 (SIRT1) has been linked to tumor progression in ESCC, prognostic significance of serum SIRT1 levels and their correlation with tissue SIRT1 remains unexplored. This study aimed to investigate the correlation between serum and tissue SIRT1 levels in patients with ESCC. A total of 38 patients diagnosed with ESCC who were untreated preoperatively were recruited for this study. SIRT1 expression in the surgical specimens was assessed through immunostaining, while serum SIRT1 levels were measured using an enzyme-linked immunosorbent assay. We analyzed the association between tissue and serum SIRT1 levels, clinicopathological features, and patient prognosis. Positive SIRT1 expression in tissue was significantly associated with deeper tumor depth (p=0.020). It was also significantly associated with poorer overall survival (OS) and relapse-free survival (RFS) (p=0.041 and p=0.012, respectively). Elevated serum SIRT1 levels were significantly correlated with increased tumor depth and weight loss (p=0.012 and p=0.030). While higher serum SIRT1 levels tended to be associated with poorer OS (p=0.069), no significant correlation was found between SIRT1 expression in tissue and its concentration in serum. SIRT1 tissue expression may be a valuable prognostic marker in ESCC. However, the clinical significance of serum SIRT1 levels appears to differ from that of its tissue expression. Future research is required to clarify the role of serum SIRT1 in ESCC.
doi_str_mv 10.21873/cdp.10393
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11534044</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3124691915</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1833-4816d51d87527112b54fa0a35a13f606f6d6612a2f3a643d8d00b34f1a1ec913</originalsourceid><addsrcrecordid>eNpVkd9L5DAQx8OhnLL64h8geRRhNZOkafskWrxTWLjjdsHHMNtO3UjbrEmr-N8b_IX3NAPz4TvznS9jRyDOJBS5Oq-b7RkIVaofbF_mSs7zvMh3vvV77DDGByGELKUCWfxke6rMhDRC7zOqfAjU4ej8wK9ofCYa-JLC1HMcGr5yMU7El7f_VsAX9ERd5G7gfxNPwxj5nRs3_Dr67QbvCTu-fJyw91PkFXUdrzDUbvA9HrDdFrtIhx91xla_rlfVzXzx5_dtdbmY11AoNdcFmCaDpsgzmQPIdaZbFKgyBNUaYVrTGAMSZavQaNUUjRBrpVtAoLoENWMX77Lbad1TU6cTA3Z2G1yP4cV6dPb_yeA29t4_WYBMaaF1Ujj5UAj-caI42t7FOnnBgZItm_6nTQll4mfs9B2tg48xUPu1B4R9i8amaOxbNAk-_n7ZF_oZhHoFJxKJYA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3124691915</pqid></control><display><type>article</type><title>Correlation Between Serum and Tissue SIRT1 Levels in Patients With Esophageal Squamous Cell Carcinoma</title><source>NCBI_PubMed Central(免费)</source><creator>Morishita, Hiroki ; Otsuka, Ryota ; Toyozumi, Takeshi ; Matsumoto, Yasunori ; Sekino, Nobufumi ; Okada, Koichiro ; Shiraishi, Tadashi ; Kamata, Toshiki ; Iida, Shinichiro ; Makiyama, Tenshi ; Nishioka, Yuri ; Yamada, Masanari ; Matsubara, Hisahiro</creator><creatorcontrib>Morishita, Hiroki ; Otsuka, Ryota ; Toyozumi, Takeshi ; Matsumoto, Yasunori ; Sekino, Nobufumi ; Okada, Koichiro ; Shiraishi, Tadashi ; Kamata, Toshiki ; Iida, Shinichiro ; Makiyama, Tenshi ; Nishioka, Yuri ; Yamada, Masanari ; Matsubara, Hisahiro</creatorcontrib><description>Identifying prognostic and molecular markers as therapeutic targets for esophageal squamous cell carcinoma (ESCC) could enhance the efficacy of multidisciplinary treatments. While tissue expression of sirtuin 1 (SIRT1) has been linked to tumor progression in ESCC, prognostic significance of serum SIRT1 levels and their correlation with tissue SIRT1 remains unexplored. This study aimed to investigate the correlation between serum and tissue SIRT1 levels in patients with ESCC. A total of 38 patients diagnosed with ESCC who were untreated preoperatively were recruited for this study. SIRT1 expression in the surgical specimens was assessed through immunostaining, while serum SIRT1 levels were measured using an enzyme-linked immunosorbent assay. We analyzed the association between tissue and serum SIRT1 levels, clinicopathological features, and patient prognosis. Positive SIRT1 expression in tissue was significantly associated with deeper tumor depth (p=0.020). It was also significantly associated with poorer overall survival (OS) and relapse-free survival (RFS) (p=0.041 and p=0.012, respectively). Elevated serum SIRT1 levels were significantly correlated with increased tumor depth and weight loss (p=0.012 and p=0.030). While higher serum SIRT1 levels tended to be associated with poorer OS (p=0.069), no significant correlation was found between SIRT1 expression in tissue and its concentration in serum. SIRT1 tissue expression may be a valuable prognostic marker in ESCC. However, the clinical significance of serum SIRT1 levels appears to differ from that of its tissue expression. Future research is required to clarify the role of serum SIRT1 in ESCC.</description><identifier>ISSN: 2732-7787</identifier><identifier>EISSN: 2732-7787</identifier><identifier>DOI: 10.21873/cdp.10393</identifier><identifier>PMID: 39502604</identifier><language>eng</language><publisher>Greece: International Institute of Anticancer Research</publisher><ispartof>Cancer diagnosis &amp; prognosis, 2024-11, Vol.4 (6), p.762-768</ispartof><rights>2024 The Author(s). Published by the International Institute of Anticancer Research.</rights><rights>2024 The Author(s). Published by the International Institute of Anticancer Research. 2024</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534044/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534044/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39502604$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morishita, Hiroki</creatorcontrib><creatorcontrib>Otsuka, Ryota</creatorcontrib><creatorcontrib>Toyozumi, Takeshi</creatorcontrib><creatorcontrib>Matsumoto, Yasunori</creatorcontrib><creatorcontrib>Sekino, Nobufumi</creatorcontrib><creatorcontrib>Okada, Koichiro</creatorcontrib><creatorcontrib>Shiraishi, Tadashi</creatorcontrib><creatorcontrib>Kamata, Toshiki</creatorcontrib><creatorcontrib>Iida, Shinichiro</creatorcontrib><creatorcontrib>Makiyama, Tenshi</creatorcontrib><creatorcontrib>Nishioka, Yuri</creatorcontrib><creatorcontrib>Yamada, Masanari</creatorcontrib><creatorcontrib>Matsubara, Hisahiro</creatorcontrib><title>Correlation Between Serum and Tissue SIRT1 Levels in Patients With Esophageal Squamous Cell Carcinoma</title><title>Cancer diagnosis &amp; prognosis</title><addtitle>Cancer Diagn Progn</addtitle><description>Identifying prognostic and molecular markers as therapeutic targets for esophageal squamous cell carcinoma (ESCC) could enhance the efficacy of multidisciplinary treatments. While tissue expression of sirtuin 1 (SIRT1) has been linked to tumor progression in ESCC, prognostic significance of serum SIRT1 levels and their correlation with tissue SIRT1 remains unexplored. This study aimed to investigate the correlation between serum and tissue SIRT1 levels in patients with ESCC. A total of 38 patients diagnosed with ESCC who were untreated preoperatively were recruited for this study. SIRT1 expression in the surgical specimens was assessed through immunostaining, while serum SIRT1 levels were measured using an enzyme-linked immunosorbent assay. We analyzed the association between tissue and serum SIRT1 levels, clinicopathological features, and patient prognosis. Positive SIRT1 expression in tissue was significantly associated with deeper tumor depth (p=0.020). It was also significantly associated with poorer overall survival (OS) and relapse-free survival (RFS) (p=0.041 and p=0.012, respectively). Elevated serum SIRT1 levels were significantly correlated with increased tumor depth and weight loss (p=0.012 and p=0.030). While higher serum SIRT1 levels tended to be associated with poorer OS (p=0.069), no significant correlation was found between SIRT1 expression in tissue and its concentration in serum. SIRT1 tissue expression may be a valuable prognostic marker in ESCC. However, the clinical significance of serum SIRT1 levels appears to differ from that of its tissue expression. Future research is required to clarify the role of serum SIRT1 in ESCC.</description><issn>2732-7787</issn><issn>2732-7787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVkd9L5DAQx8OhnLL64h8geRRhNZOkafskWrxTWLjjdsHHMNtO3UjbrEmr-N8b_IX3NAPz4TvznS9jRyDOJBS5Oq-b7RkIVaofbF_mSs7zvMh3vvV77DDGByGELKUCWfxke6rMhDRC7zOqfAjU4ej8wK9ofCYa-JLC1HMcGr5yMU7El7f_VsAX9ERd5G7gfxNPwxj5nRs3_Dr67QbvCTu-fJyw91PkFXUdrzDUbvA9HrDdFrtIhx91xla_rlfVzXzx5_dtdbmY11AoNdcFmCaDpsgzmQPIdaZbFKgyBNUaYVrTGAMSZavQaNUUjRBrpVtAoLoENWMX77Lbad1TU6cTA3Z2G1yP4cV6dPb_yeA29t4_WYBMaaF1Ujj5UAj-caI42t7FOnnBgZItm_6nTQll4mfs9B2tg48xUPu1B4R9i8amaOxbNAk-_n7ZF_oZhHoFJxKJYA</recordid><startdate>202411</startdate><enddate>202411</enddate><creator>Morishita, Hiroki</creator><creator>Otsuka, Ryota</creator><creator>Toyozumi, Takeshi</creator><creator>Matsumoto, Yasunori</creator><creator>Sekino, Nobufumi</creator><creator>Okada, Koichiro</creator><creator>Shiraishi, Tadashi</creator><creator>Kamata, Toshiki</creator><creator>Iida, Shinichiro</creator><creator>Makiyama, Tenshi</creator><creator>Nishioka, Yuri</creator><creator>Yamada, Masanari</creator><creator>Matsubara, Hisahiro</creator><general>International Institute of Anticancer Research</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202411</creationdate><title>Correlation Between Serum and Tissue SIRT1 Levels in Patients With Esophageal Squamous Cell Carcinoma</title><author>Morishita, Hiroki ; Otsuka, Ryota ; Toyozumi, Takeshi ; Matsumoto, Yasunori ; Sekino, Nobufumi ; Okada, Koichiro ; Shiraishi, Tadashi ; Kamata, Toshiki ; Iida, Shinichiro ; Makiyama, Tenshi ; Nishioka, Yuri ; Yamada, Masanari ; Matsubara, Hisahiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1833-4816d51d87527112b54fa0a35a13f606f6d6612a2f3a643d8d00b34f1a1ec913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Morishita, Hiroki</creatorcontrib><creatorcontrib>Otsuka, Ryota</creatorcontrib><creatorcontrib>Toyozumi, Takeshi</creatorcontrib><creatorcontrib>Matsumoto, Yasunori</creatorcontrib><creatorcontrib>Sekino, Nobufumi</creatorcontrib><creatorcontrib>Okada, Koichiro</creatorcontrib><creatorcontrib>Shiraishi, Tadashi</creatorcontrib><creatorcontrib>Kamata, Toshiki</creatorcontrib><creatorcontrib>Iida, Shinichiro</creatorcontrib><creatorcontrib>Makiyama, Tenshi</creatorcontrib><creatorcontrib>Nishioka, Yuri</creatorcontrib><creatorcontrib>Yamada, Masanari</creatorcontrib><creatorcontrib>Matsubara, Hisahiro</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer diagnosis &amp; prognosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morishita, Hiroki</au><au>Otsuka, Ryota</au><au>Toyozumi, Takeshi</au><au>Matsumoto, Yasunori</au><au>Sekino, Nobufumi</au><au>Okada, Koichiro</au><au>Shiraishi, Tadashi</au><au>Kamata, Toshiki</au><au>Iida, Shinichiro</au><au>Makiyama, Tenshi</au><au>Nishioka, Yuri</au><au>Yamada, Masanari</au><au>Matsubara, Hisahiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correlation Between Serum and Tissue SIRT1 Levels in Patients With Esophageal Squamous Cell Carcinoma</atitle><jtitle>Cancer diagnosis &amp; prognosis</jtitle><addtitle>Cancer Diagn Progn</addtitle><date>2024-11</date><risdate>2024</risdate><volume>4</volume><issue>6</issue><spage>762</spage><epage>768</epage><pages>762-768</pages><issn>2732-7787</issn><eissn>2732-7787</eissn><abstract>Identifying prognostic and molecular markers as therapeutic targets for esophageal squamous cell carcinoma (ESCC) could enhance the efficacy of multidisciplinary treatments. While tissue expression of sirtuin 1 (SIRT1) has been linked to tumor progression in ESCC, prognostic significance of serum SIRT1 levels and their correlation with tissue SIRT1 remains unexplored. This study aimed to investigate the correlation between serum and tissue SIRT1 levels in patients with ESCC. A total of 38 patients diagnosed with ESCC who were untreated preoperatively were recruited for this study. SIRT1 expression in the surgical specimens was assessed through immunostaining, while serum SIRT1 levels were measured using an enzyme-linked immunosorbent assay. We analyzed the association between tissue and serum SIRT1 levels, clinicopathological features, and patient prognosis. Positive SIRT1 expression in tissue was significantly associated with deeper tumor depth (p=0.020). It was also significantly associated with poorer overall survival (OS) and relapse-free survival (RFS) (p=0.041 and p=0.012, respectively). Elevated serum SIRT1 levels were significantly correlated with increased tumor depth and weight loss (p=0.012 and p=0.030). While higher serum SIRT1 levels tended to be associated with poorer OS (p=0.069), no significant correlation was found between SIRT1 expression in tissue and its concentration in serum. SIRT1 tissue expression may be a valuable prognostic marker in ESCC. However, the clinical significance of serum SIRT1 levels appears to differ from that of its tissue expression. Future research is required to clarify the role of serum SIRT1 in ESCC.</abstract><cop>Greece</cop><pub>International Institute of Anticancer Research</pub><pmid>39502604</pmid><doi>10.21873/cdp.10393</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2732-7787
ispartof Cancer diagnosis & prognosis, 2024-11, Vol.4 (6), p.762-768
issn 2732-7787
2732-7787
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11534044
source NCBI_PubMed Central(免费)
title Correlation Between Serum and Tissue SIRT1 Levels in Patients With Esophageal Squamous Cell Carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T04%3A14%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correlation%20Between%20Serum%20and%20Tissue%20SIRT1%20Levels%20in%20Patients%20With%20Esophageal%20Squamous%20Cell%20Carcinoma&rft.jtitle=Cancer%20diagnosis%20&%20prognosis&rft.au=Morishita,%20Hiroki&rft.date=2024-11&rft.volume=4&rft.issue=6&rft.spage=762&rft.epage=768&rft.pages=762-768&rft.issn=2732-7787&rft.eissn=2732-7787&rft_id=info:doi/10.21873/cdp.10393&rft_dat=%3Cproquest_pubme%3E3124691915%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1833-4816d51d87527112b54fa0a35a13f606f6d6612a2f3a643d8d00b34f1a1ec913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3124691915&rft_id=info:pmid/39502604&rfr_iscdi=true